Latest News

Date Title Topic
26 Nov 2013 European Medicines Agency Recommends Refusal of the Marketing Authorisation for Masitinib Sarcomas - Anticancer agents & Biologic therapy
25 Nov 2013 Immuno-Oncology 2013 Webcasts
25 Nov 2013 European Medicines Agency Recommends Change in Indication for Cetuximab to RAS Wild-type Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
21 Nov 2013 Continuation of Bevacizumab with Second-Line Chemotherapy after the Standard First-Line Bevacizumab-Containing Therapy in mCRC: What is the value of KRAS status? Gastrointestinal cancers
20 Nov 2013 Clinical Predictors of Acute Urinary Symptoms after Radiotherapy for Prostate Cancer Genitourinary cancers
19 Nov 2013 ESMO Press Release: ESMO Spearheads International Collaboration to Assure Patient Access to Safe and Effective Cancer Medicines
19 Nov 2013 Screening Programme for Efficient Clinical Trial Access – Lung Cancer Biomarker Screening Platform Personalised medicine - Lung and other thoracic tumours
12 Nov 2013 Prognostic Value of Baseline Quality-of-Life Data for Survival in Different Types of Cancer Palliative and supportive care
08 Nov 2013 Long Term Results of EORTC Trial of Perioperative FOLFOX4 Versus Surgery Alone Gastrointestinal cancers
07 Nov 2013 International Osteoporosis Foundation Working Group Provides Guidance on Fracture Prevention in Cancer-associated Bone Disease Palliative and supportive care
06 Nov 2013 A New Study Evaluates Early Autologous Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphoma Haematologic malignancies
06 Nov 2013 A Pilot Study Shows Next-Generation Sequencing Feasibility in Patients with Advanced Cancers Personalised medicine
05 Nov 2013 New Study Analyses Barriers to Academic-based Cancer Research Commercialisation Bioethics, legal and economic issues
04 Nov 2013 Afatinib Activity in Uncommon EGFR Mutation-Positive Lung Cancer Personalised medicine - Lung and other thoracic tumours